[开放获取]    关节病型银屑病早期诊断与治疗的研究进展

doi:10.35541/cjd.20240376

Abstract

Abstract: 【Abstract】 Psoriatic arthritis （PsA） is a chronic inflammatory arthropathy involving the muscles, bones, skin, and nails. PsA can lead to joint and periarticular soft tissue swelling, pain, and stiffness, and in advanced stages may result in joint ankylosis, deformity, and even disability. Early initiation of standardized treatment within 2 years of disease onset can significantly reduce joint damage in patients with PsA. Therefore, early diagnosis and treatment are crucial for improving prognosis. Based on current domestic and international research, this article reviews recent advances in the early diagnosis and treatment of PsA.

Key words: Arthritis, psoriatic, Early diagnosis, Therapy, Diagnosis, differential, Pathogenesis, Early screening

Yang Yuan, Deng Danqi. Early diagnosis and treatment of psoriatic arthritis[J]. Chinese Journal of Dermatology,2026,e20240376. doi:10.35541/cjd.20240376

References ［42］

［1］	FitzGerald O, Ogdie A, Chandran V, et al. Psoriatic arthritis［J］. Nat Rev Dis Primers, 2021,7（1）:59. DOI: 10.1038/s41572⁃021⁃00293⁃y.
［2］	van der Heijde D, Gladman DD, Kavanaugh A, et al. Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research［J］. Arthritis Res Ther, 2020,22（1）:18. DOI: 10.1186/s13075⁃020⁃2103⁃8.
［3］	Ortolan A, Lorenzin M, Tadiotto G, et al. Metabolic syndrome, non⁃alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients［J］. Clin Rheumatol, 2019,38（10）:2843⁃2850. DOI: 10.1007/s10067⁃019⁃04646⁃7.
［4］	Paine A, Brookes PS, Bhattacharya S, et al. Dysregulation of bile acids, lipids, and nucleotides in psoriatic arthritis revealed by unbiased profiling of serum metabolites［J］. Arthritis Rheumatol, 2023,75（1）:53⁃63. DOI: 10.1002/art.42288.
［5］	Elmets CA, Leonardi CL, Davis D, et al. Joint AAD⁃NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities［J］. J Am Acad Dermatol, 2019,80（4）:1073⁃1113. DOI: 10.1016/j.jaad.2018. 11.058.
［6］	Triantafyllias K, Liverakos S, Muthuraman M, et al. Cardiovascular risk evaluation in psoriatic arthritis by aortic stiffness and the systemic coronary risk evaluation （SCORE）: results of the prospective PSOCARD cohort study［J］. Rheumatol Ther, 2024,11（4）:897⁃911. DOI: 10.1007/s40744⁃024⁃00676⁃z.
［7］	Theodorakopoulou E, Dalamaga M, Katsimbri P, et al. How does the joint dermatology⁃rheumatology clinic benefit both patients and dermatologists?［J］. Dermatol Ther, 2020,33（3）:e13283. DOI: 10.1111/dth.13283.
［8］	Azuaga AB, Ramírez J, Cañete JD. Psoriatic arthritis: pathogenesis and targeted therapies［J］. Int J Mol Sci, 2023,24（5）：4901. DOI: 10.3390/ijms24054901.
［9］	孟景红, 赵海涛, 陈海英. 银屑病关节炎发病机制的研究进展［J］. 中国免疫学杂志, 2021,37（1）:119⁃123. DOI: 10.3969/j.issn.1000⁃484X.2021.01.023.
［10］	王蕊, 刘彬. 银屑病性关节炎的最新研究进展［J］. 吉林医学, 2024,45（2）:448⁃452. DOI: 10.3969/j.issn.1004⁃0412.2024.02.062.
［11］	Stober C. Pathogenesis of psoriatic arthritis［J］. Best Pract Res Clin Rheumatol, 2021,35（2）:101694. DOI: 10.1016/j.berh.2021. 101694.
［12］	Karreman MC, Weel A, van der Ven M, et al. Performance of screening tools for psoriatic arthritis: a cross⁃sectional study in primary care［J］. Rheumatology （Oxford）, 2017,56（4）:597⁃602. DOI: 10.1093/rheumatology/kew410.
［13］	Khraishi M, Mong J, Mugford G, et al. The electronic Psoriasis and Arthritis Screening Questionnaire （ePASQ）: a sensitive and specific tool to diagnose psoriatic arthritis patients［J］. J Cutan Med Surg, 2011,15（3）:143⁃149. DOI: 10.2310/7750.2011.10018.
［14］	Urruticoechea⁃Arana A, Benavent D, León F, et al. Psoriatic arthritis screening: a systematic literature review and experts' recommendations［J］. PLoS One, 2021,16（3）:e0248571. DOI: 10. 1371/journal.pone.0248571.
［15］	戴生明. 加强筛查问卷的应用尽早发现银屑病关节炎［J］. 中国医学前沿杂志, 2022,14（8）:1⁃6. DOI: 10.12037/YXQY. 2022.08⁃01.
［16］	Cui R, Chen M, Li X, et al. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: a multicenter study［J］. J Dermatol, 2022,49（6）:615⁃623. DOI: 10.1111/1346⁃8138.16355.
［17］	Liu P, Kuang Y, Ye L, et al. Predicting the risk of psoriatic arthritis in plaque psoriasis patients: development and assessment of a new predictive nomogram［J］. Front Immunol, 2021,12:740968. DOI: 10.3389/fimmu.2021.740968.
［18］	Haddad A, Elkayam PC, Stein N, et al. Epidemiological trends in psoriatic arthritis: a comprehensive population⁃based study［J］. Arthritis Res Ther, 2024,26（1）:108. DOI: 10.1186/s13075⁃024⁃03339⁃0.
［19］	Karmacharya P, Crowson CS, Bekele D, et al. The epidemiology of psoriatic arthritis over five decades: a population⁃based study［J］. Arthritis Rheumatol, 2021,73（10）:1878⁃1885. DOI: 10. 1002/art.41741.
［20］	Yang Q, Qu L, Tian H, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis［J］. J Eur Acad Dermatol Venereol, 2011,25（12）:1409⁃1414. DOI: 10. 1111/j.1468⁃3083.2011.03985.x.
［21］	Loo WY, Tee YC, Han WH, et al. Predictive factors of psoriatic arthritis in a diverse population with psoriasis［J］. J Int Med Res, 2024,52（1）:3000605231221014. DOI: 10.1177/0300060523122 1014.
［22］	《中国关节病型银屑病诊疗共识（2020）》编写委员会专家组. 中国关节病型银屑病诊疗共识（2020）［J］. 中华皮肤科杂志, 2020,53（8）:585⁃595. DOI: 10.35541/cjd.20200369.
［23］	Zabotti A, De Marco G, Gossec L, et al. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis［J］. Ann Rheum Dis, 2023,82（9）:1162⁃1170. DOI: 10.1136/ard⁃2023⁃224148.
［24］	Zabotti A, Fagni F, Gossec L, et al. Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage［J］. RMD Open, 2024,10（2）:e004314. DOI: 10.1136/rmdopen⁃2024⁃004314.
［25］	杨闵, 李薇. 关节病型银屑病的早期筛查及规范化关节评估［J］. 中国皮肤性病学杂志, 2021,35（4）:469⁃472. DOI: 10.13735/ j.cjdv.1001⁃7089.202010115.
［26］	Mease PJ, Liu M, Rebello S, et al. Association of nail psoriasis with disease activity measures and impact in psoriatic arthritis: data from the corrona psoriatic arthritis/spondyloarthritis registry［J］. J Rheumatol, 2021,48（4）:520⁃526. DOI: 10.3899/jrheum. 190923.
［27］	Gottlieb AB, Merola JF. Axial psoriatic arthritis: an update for dermatologists［J］. J Am Acad Dermatol, 2021,84（1）:92⁃101. DOI: 10.1016/j.jaad.2020.05.089.
［28］	Dubash SR, De Marco G, Wakefield RJ, et al. Ultrasound imaging in psoriatic arthritis: what have we learnt in the last five years?［J］. Front Med （Lausanne）, 2020,7:487. DOI: 10.3389/fmed.2020.00487.
［29］	Jin Y, Cheng IT, Wu D, et al. Imaging in psoriatic arthritis: established methods and emerging techniques［J］. Ther Adv Musculoskelet Dis, 2024,16:1759720X241288060. DOI: 10.1177/ 1759720X241288060.
［30］	Huang YS, Huang YH, Lin CH, et al. Ultrasound can be usefully integrated with the clinical assessment of nail and enthesis involvement in psoriasis and psoriatic arthritis［J］. J Clin Med, 2022,11（21）:6296. DOI: 10.3390/jcm11216296.
［31］	Hioki T, Komine M, Ohtsuki M. Diagnosis and intervention in early psoriatic arthritis［J］. J Clin Med, 2022,11（7）:2051. DOI: 10.3390/jcm11072051.
［32］	Yang F, Lu C, Liu H, et al. Enthesitis in patients with psoriatic arthritis: a nationwide data from the Chinese Registry of Psoriatic Arthritis （CREPAR）［J］. Chin Med J （Engl）, 2023,136（8）:951⁃958. DOI: 10.1097/CM9.0000000000002646.
［33］	Ocampo D V, Gladman D. Psoriatic arthritis［J］. F1000Res, 2019,8:1665. DOI: 10.12688/f1000research.19144.1.
［34］	Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists［J］. J Dermatolog Treat, 2020,31（7）:662⁃679. DOI: 10.1080/09546 634.2019.1605142.
［35］	Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review［J］. JAMA, 2018,320（13）:1360⁃1372. DOI: 10.1001/jama.2018.13103.
［36］	Agrawal P, Tote S, Sapkale B. Diagnosis and treatment of ankylosing spondylitis［J］. Cureus, 2024,16（1）:e52559. DOI: 10.7759/cureus.52559.
［37］	Saalfeld W, Mixon AM, Zelie J, et al. Differentiating psoriatic arthritis from osteoarthritis and rheumatoid arthritis: a narrative review and guide for advanced practice providers［J］. Rheumatol Ther, 2021,8（4）:1493⁃1517. DOI: 10.1007/s40744⁃021⁃00 365⁃1.
［38］	Coates LC, Soriano ER, Corp N, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis （GRAPPA）: updated treatment recommendations for psoriatic arthritis 2021［J］. Nat Rev Rheumatol, 2022,18（8）:465⁃479. DOI: 10.1038/s41584⁃022⁃00798⁃0.
［39］	Tucker L, Allen A, Chandler D, et al. The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs［J］. Rheumatology （Oxford）, 2022,61（9）:e255⁃e266. DOI: 10.1093/rheumatology/keac295.
［40］	Ogdie A, Coates LC, Gladman DD. Treatment guidelines in psoriatic arthritis［J］. Rheumatology （Oxford）, 2020,59（Suppl 1）:i37⁃i46. DOI: 10.1093/rheumatology/kez383.
［41］	Mease PJ, Baraliakos X, Chandran V, et al. Persistent patient⁃level effect of guselkumab at consecutive 8⁃week dosing visits and over time in patients with active psoriatic arthritis: post hoc analysis of a 2⁃year, phase 3, randomized, controlled study［J］. ACR Open Rheumatol, 2024,6（12）:880⁃890. DOI: 10.1002/acr2. 11732.
［42］	Carneiro S, Palominos PE, Anti S, et al. Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis［J］. Adv Rheumatol, 2021,61（1）:69. DOI: 10.1186/s42358⁃021⁃00219⁃y.

[1]	Sun Songpeng, Long Junhong, Cao Bo, Xu Yue, Zhang Xiang′an, Cao Hui, Xie Jun, Gui Ping, Sun Xiaojun, Zhang Bo, Xu Zhijie, Li Jin′an, Wang Zhigang, Wu Wei, Yang Huiju, Wei Ping, Liu Congcong, Shen Qingbo, Yu Fan, Chu Hongchuan, Zhou Yangyang, Liu Jiaxin, Liu Yan, Huo Xingxiao, Chen Hang, Jing Tao, Gao Jing, Wang Yanxun, Wang Rui, Li Zhenyu, Zhang Shuxin. Efficacy and safety of Fuzhiqing ointment versus triamcinolone acetonide and econazole nitrate cream in the treatment of chronic perianal eczema: a multicenter, randomized, double?blind, controlled, equivalence trial [J]. Chinese Journal of Dermatology, 2026, 0(5): 20250421-e20250421.
[2]	Chen Xue, Zhang Jianzhong. Chronic hand eczema: epidemiology, disease burden, pathogenesis, and management [J]. Chinese Journal of Dermatology, 2026, 59(4): 327-332.
[3]	Xue Shuyue, Li Tingting, Kang Xiaojing. Lipid metabolism in the occurrence, development, diagnosis and treatment of cutaneous malignancies [J]. Chinese Journal of Dermatology, 2026, 59(4): 379-382.
[4]	Huang Chinin, Ma Yinchao, Wang Ziyuan, Lu Xilin, Qi Yingting, Liu Ziyan, Men Yuehua, Chu Ming, Zhang Chunlei. Effects of berberine ointment on skin inflammation and microbiota in an atopic dermatitis-like mouse model [J]. Chinese Journal of Dermatology, 2026, 59(4): 353-360.
[5]	Group on Children, Chinese Society of Dermatology, Pediatric Dermatology Group, Chinese Association of Rehabilitation Dermatology, Pediatric Dermatology Group, China Dermatologist Association, External Therapy Group, Professional Committee for Children's Health and Drug Research, China Association of Traditional Chinese Medicine, Dermatology Group, China Pediatrician Association. Expert consensus on the diagnosis and treatment of pediatric alopecia areata in China （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(4): 291-303.
[6]	Tan Yaxin, Zhi Juan, Zhao Jiaojiao, Lei Jin, Liu Juan. A half-face controlled study on the treatment of facial atrophic scars with fractional laser and acupuncture combined with negative pressure suction [J]. Chinese Journal of Dermatology, 2026, 59(4): 361-365.
[7]	Yang Wanqing, Chen Nuoran, Meng Xiaoqi, Liu Tingwei, Xu Yang. Application of focused ultrasound in dermatology beyond the anti?aging aspects [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240433-e20240433.
[8]	Zeng Wanxin, Wen Xiang. Photoelectric therapy for hypertrophic scars [J]. Chinese Journal of Dermatology, 2026, 59(3): 269-273.
[9]	Xia Zhikuan, Ge Ge. Laser therapy for vitiligo: clinical applications and prospects [J]. Chinese Journal of Dermatology, 2026, 59(3): 213-217.
[10]	Expert Group on the Interpretation of the "Chinese expert consensus on the clinical application of photobiomodulation therapy in dermatology （）", Laser Medicine Group, Chinese Society of Dermatology. Interpretation of the Chinese expert consensus on the clinical application of photobiomodulation therapy in dermatology （2025） [J]. Chinese Journal of Dermatology, 2026, 59(3): 208-212.
[11]	Wang Juncheng, Liu Jie. Artificial intelligence in psoriasis: diagnosis, treatment and patient management [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240061-e20240061.
[12]	Xu Zhuohong, Zhou Huan, Hu Yu, Gu Heng. Balneotherapy in skin diseases [J]. Chinese Journal of Dermatology, 2026, 0(3): 20250531-e20250531.
[13]	Wang Li, Wang Qianqiu, Zhang Ruili. Research progress in latent syphilis [J]. Chinese Journal of Dermatology, 2026, 59(3): 286-289.
[14]	Zhou Yuting, Song Qinghua, Wang Wenhui. Susceptibility genes of generalized pustular psoriasis [J]. Chinese Journal of Dermatology, 2026, 0(3): 20240211-e20240211.
[15]	Liu Lihao, Hu Yu, Chen Kun. Clinical application and development of photobiomodulation in dermatology [J]. Chinese Journal of Dermatology, 2026, 59(3): 278-282.

Early diagnosis and treatment of psoriatic arthritis

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［42］

Related Articles 15

Metrics

Comments

Recommended 0